Follow‐up of complaints and recurrence after laparoscopic surgery of benign adnexal tumours
article
OA: closed
CC0
AI-generated summary
Laparoscopic surgery for benign adnexal tumors resulted in significantly decreased complaints, successful pregnancies in 51% of desiring women, a 4.8% recurrence rate, and few postoperative complications.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective To examine the long‐term experience of laparoscopic cystectomy for benign adnexal tumours by analysing follow‐up visits, ultrasound re‐examination and questionnaires. Results Recurrence of benign nonfunctional ovarian cysts treated by cystectomy, after an average follow‐up of 23 months, was 4.8%, and 3% of the patients had some minor postoperative complications. Of the women who wanted to become pregnant after conservational treatment, 51% succeeded. Complaints decreased significantly after the operation and these changes persisted. Conclusion After conservational laparoscopic surgery of adnexal cysts, complaints decreased significantly and the patients fulfilled the desire of pregnancy in around 50% of cases. The recurrence rate is low and only a few postoperative complications occurred.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
References (14)
- Endoscopic versus laparotomy management of endometriomas via openalex
- Laparoscopy versus microsurgery by laparotomy for moderate and severe endometriosis via openalex
- Ovarian function after conservational ovarian surgery: A long‐term follow‐up study via openalex
- W1964199637 via openalex
- W2096129124 via openalex
- W2164136848 via openalex
- W2297749539 via openalex
- W2322766198 via openalex
- W2400337287 via openalex
- W2539213332 via openalex
- W4245052256 via openalex
- W4285719527 via openalex
- W96120555 via openalex
- W151519830 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK